Treatment of hemospermia with transprostatic utricle seminal vesiculoscopy
10.3760/cma.j.issn.1673-4904.2017.06.017
- VernacularTitle:经前列腺小囊精囊镜治疗血精症的体会
- Author:
Wei HE
;
Hongjian LIU
;
Yougang FENG
;
Yongming KANG
;
Zhou YU
;
Mingdong JIANG
- Keywords:
Hemospermia;
Seminal vesicles;
Inflammation
- From:
Chinese Journal of Postgraduates of Medicine
2017;40(6):549-551
- CountryChina
- Language:Chinese
-
Abstract:
Objective To determine the feasibility and safety of transprostatic utricle seminal vesiculoscopy in the treatment of hemospermia. Methods Totally 11 patients with hemospermia, mean age of (46.6 ± 3.5) years, ranging from 38 to 68 years, for 3 months admitted from September 2012 to August 2015 were enrolled, Their main manifestations were hemospermia. Painful ejaculation was observed in 7 patients, and perineal and testicular pain occured in 4 patients. They all underwent transprostatic utricle seminal vesiculoscopy, and then were followed up for 3 to 6 months. Results Ten patients were operated successfully, but 1 patient failed. The operation revealed that the causes of hemospermia were seminal vesiculitis in 8 cases, seminal vesiculitis accompanied with seminal calculi in 2 cases, and ejaculatory duct cyst in 1 case. Operation time was (29.2 ± 3.2) min ( ranging from 25 to 37 min) , and hospital stay was 2 d ( from 2 to 4 d). Hemospermia disappeared in 10 patients within 1 month of surgery, and hemospermia recurrence was observed in 1 patient within 6 months. The patient was treated with transprostatic utricle Holmium laser incision, then hemospermia was dispeared,Two cases of postoperative epididymitis were cured after one week of antibiotic treatment. Conclusions Seminal vesiculoscopy is a safe and effective to treat hemaospermia.
